Your browser doesn't support javascript.
loading
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study.
Tan, Peter; Tiong, Ing Soo; Fleming, Shaun; Pomilio, Giovanna; Cummings, Nik; Droogleever, Mark; McManus, Julie; Schwarer, Anthony; Catalano, John; Patil, Sushrut; Avery, Sharon; Spencer, Andrew; Wei, Andrew.
Afiliación
  • Tan P; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
  • Tiong IS; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
  • Fleming S; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
  • Pomilio G; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
  • Cummings N; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
  • Droogleever M; Department of Pathology, Alfred Hospital, Melbourne, Australia.
  • McManus J; Faculty of Medicine, University of Amsterdam, Amsterdam, The Netherlands.
  • Schwarer A; Department of Pathology, Alfred Hospital, Melbourne, Australia.
  • Catalano J; Eastern Health Clinical School, Monash University, Box Hill, Australia.
  • Patil S; Clinical Haematology, Frankston Hospital, Frankston, Australia.
  • Avery S; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
  • Wei A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia.
Oncotarget ; 8(32): 52269-52280, 2017 Aug 08.
Article en En | MEDLINE | ID: mdl-28881728

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos